PREM14A

PRELIMINARY PROXY STATEMENT

Company: Immunovant, Inc.
Filed: October 2, 2019
Period of Report: October 2, 2019
Accession Number: 0001213900-19-019471

View Document ↗ View on SEC.gov ↗